Agile Therapeutics, Inc. (OTCQB:AGRX) Q1 2022 Results Conference Call May 12, 2022 4:30 PM ET Company Participants Matt Riley - Head, IR Al Altomari - Chairman, CEO Dennis Reilly - CFO Conference Call Participants Oren Livnat - H.C. Wainwright Operator Good afternoon, and welcome to the Agile Therapeutics’ First Quarter 2022 Financial Results Conference Call. Please note, today's event is being recorded. I would now like to turn the conference over to Matt Riley, Head of Investors Relations. Matt Riley Hel ...

Agile Therapeutics, Inc. (OTCQB:AGRX) Q4 2021 Earnings Conference Call March 30, 2022 4:30 PM ET Company Participants Matt Riley - Head of Investors Relations Dennis Reilly - Chief Financial Officer Al Altomari - Chairman and Chief Executive Officer Conference Call Participants Leland Gershell - Oppenheimer Oren Livnat - H.C. Wainwright Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you na ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36464 Agile Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 23-2936302 (State or other jurisdictio ...

Agile Therapeutics, Inc. (OTCQB:AGRX) Q3 2021 Results Conference Call November 2, 2021 4:30 PM ET Company Participants Matthew Riley - Head of Investor Relations and Corporate Communications Alfred Altomari - Chairman and Chief Executive Officer Dennis Reilly - Chief Financial Officer Conference Call Participants Leland Gershell - Oppenheimer Oren Livnat - H.C. Wainwright Timothy Lugo - William Blair & Company Operator Good afternoon, and welcome to the Agile Therapeutics’ Third Quarter 2021 Financial Resul ...

Agile Therapeutics, Inc. (OTCQB:AGRX) Q2 2021 Earnings Conference Call July 26, 2021 4:30 PM ET Company Participants Matt Riley - Head, Investors Relations Al Altomari - Chairman and CEO Dennis Reilly - Chief Financial Officer Conference Call Participants Oren Livnat - H.C. Wainwright Tim Lugo - William Blair Leland Gershell - Oppenheimer Daniel Busby - RBC Capital Markets Naz Rahman - Maxim Group Operator Good day, and thank you for standing by. And welcome to the Agile Therapeutics’ 20 -- Q2 2021 Financia ...